| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
in Rat Kidney with Ischemia-Reperfusion Injury






*
Division of Nephrology, Department of Internal Medicine, Kangnam St.
Mary's Hospital, The Catholic University of Korea, Seoul, Korea
Department of Anatomy, The College of Medicine, The Catholic University of
Korea, Seoul, Korea
Institute of Anatomy, University of Freiburg, Freiburg,
Germany.
Correspondence to Dr. Jung Ho Cha, Associate Professor, Department of Anatomy, The Catholic University of Korea, 505 Banpo-Dong, Seocho-Ku, 137-701, Seoul, Korea. Phone: 82-2-590-1163; Fax: 82-2-536-3110; E-mail: jhcha{at}cmc.cuk.ac.kr
| Abstract |
|---|
|
|
|---|
(CNTFR
) was analyzed in the ischemic rat kidney. An
ischemia/reperfusion (I/R) injury was induced by clamping both renal arteries
for 45 min. Animals were killed at 1, 2, 3, 5, 7, 14, and 28 d after ischemia.
The expression of CNTF and CNTFR
was monitored by reverse
transcription-PCR, in situ hybridization, immunoblotting,
immunohistochemistry, and electron microscopy. In sham-operated rat kidneys,
CNTF expression was weak and limited to the descending thin limb of the loop
of Henle. With I/R injury, CNTF mRNA and protein expressions were strikingly
increased as compared with the sham-operated rat kidney, and the
immunoreactivity of CNTF was mainly observed in the regenerating proximal
tubules. The expression of CNTFR
mRNA was also increased after I/R
injury, and its location and expression patterns were similar to the
expression of CNTF. These findings suggest a possible role of CNTF as a growth
factor during renal tubular repair processes after I/R injury and an autocrine
or paracrine function of CNTF acting against CNTFR
. | Introduction |
|---|
|
|
|---|
Several growth factors have been identified in the kidney, and these growth factors act in a coordinated manner. Of these, epidermal growth factor, insulin-like growth factor-1, and hepatocyte growth factor are well known (5). In addition, heparin-binding epidermal growth factor-like growth factor (6), fibroblast growth factor (7), and transforming growth factor-ß1 (8) are associated with the repair process. Additional growth factors are believed to be involved in the repair process after ischemic injury because of the complicated nature of the process.
Ciliary neurotrophic factor (CNTF) was originally identified as a trophic molecule for the survival of embryonic chicken ciliary neurons in vitro (9). Subsequent studies have shown that CNTF is a neuronal growth factor that has a regulatory role in local neuronal healing and regeneration (10,11). The CNTF mRNA and protein are widely expressed in the brain, heart, lung, liver, kidney, and testis of the rat, in addition to preferential expression in the sciatic nerve (12,13). Apart from neuronal tissue, CNTF is most abundant in the kidney, but its role and precise localization are yet to be determined.
The effects of CNTF are mediated by a CNTF-specific ligand-binding
subunit (CNTFR
)
(14,15).
Functionally, CNTF receptors are critical for the developing nervous system
and are needed to sustain life. Whereas disruption of the CNTF gene results in
only modest changes within the central nervous system
(16), mice with the CNTFR
null mutation ("knockouts") die during the perinatal
period and display profound neuron damage
(17). The expression of CNTFR
mRNA is restricted primarily to nervous system and skeletal muscle,
and a small amount of CNTFR
mRNA is present in the kidney
(18)
From the data that have accumulated on the role of CNTF as a growth factor
in nervous tissue, we hypothesized that CNTF may play a role as a growth
factor in the kidney. To test this, the response of CNTF and CNTFR
to
ischemia/reperfusion (I/R) injury was evaluated during regeneration of renal
tubular cells after I/R injury. Our findings support the hypothesis.
| Materials and Methods |
|---|
|
|
|---|
Preservation of Kidneys
The kidneys were perfused briefly through the abdominal aorta with
phosphate-buffered saline (PBS) to rinse out the blood and subsequently were
fixed by in vivo perfusion with a periodate-lysine-paraformaldehyde
(PLP) solution for 4 min. They were cut into sagittal slices and then immersed
in PLP overnight at 4°C. After being rinsed in PBS, tissues were
dehydrated in a graded series of ethanol and embedded in wax (polyethylene
glyco 400 disterate; Polysciences, Inc., Warrington, PA). For
immunohistochemistry using a pre-embedding method, PLP-fixed tissues were cut
on a vibratome (Lancer Vibratomes Series 10 00; Technical Products
International, St. Louis, MO) to a thickness of 50 µm.
Immunohistochemistry for Proliferating Cell Nuclear Antigen and
CNTF
Wax sections were dewaxed and hydrated through the ethanol series and were
immunostained with the primary antibody to proliferating cell nuclear antigen
(PCNA; PC-10, DAKO, Glostrup, Denmark) using Vectastain ABC kit (Vector
Laboratories, Burlington, CA) according to the manufacturer's instructions.
Diaminobenzidine was used as chromogen. After immunostaining, sections were
counterstained with hematoxylin.
Immunohistochemistry using a pre-embeddedmethod was performed as described previously (19). The 50-µm-thick vibratome sections were washed with 50 mM NH 4Cl in PBS. Before incubation with primary antibody, the tissue sections were incubated for 3 h with PBS containing 1% bovine serum albumin, 0.05% saponin, and 0.2% gelatin (solution A). Tissue sections were then incubated overnight at 4°C with monoclonal antibody against CNTF (diluted to 1:10; Chemicon International Inc., Temecula, CA) in PBS containing 1% bovine serum albumin (solution B). After washes with solution A, the tissue sections were incubated for 2 h with peroxidase-conjugated goat anti-mouse IgG Fab fragment (Jackson ImmunoResearch Laboratories, West Grove, PA), diluted 1:50 in solution B. The tissues were then rinsed, first in solution A and subsequently in 0.05 M Tris buffer (pH 7.6). For the detection of horseradish peroxidase, the sections were incubated in 0.1% 3,3'-diaminobenzidine in 0.05 M Tris buffer for 5 min, after which H 2O 2 was added to a final concentration of 0.01. After the sections were washed with 0.05 M Tris buffer, they were dehydrated in a graded series of ethanol and embedded in Epon-812. The embedded 50-µm-thick sections were examined, and 1 µm of semi-thin sections were cut and photographed on Olympus Photomicroscope (Tokyo, Japan) equipped with differential-interference contrast.
For the immunoelectron microscopy, some of the immunostained vibratome sections were postfixed with 1% osmium tetroxide and embedded in Epon-812. Ultrathin sections were stained with lead citrate and observed with a transmission electron microscope (1200EX, JOEL, Tokyo, Japan).
Semiquantitative Reverse Transcription-PCR for CNTF mRNA and CNTFR
mRNA
Total RNA was isolated from Tri Reagent (MRC, Cincinnati, OH) according to
the manufacturer's instructions. First-strand cDNA was reverse-transcribed
from the RNA using random hexanucleotide primers (Life Technologies,
Gaithersburg, MD) and Moloney murine leukemia virus reverse transcriptase
(Life Technologies) as previously prescribed
(20). The cDNA was then
amplified by PCR for 25 to 30 cycles. Ten µl of each reaction cup was run
on a 1.5% agarose gel, which contained 1 µg/ml ethidium bromide. Reverse
transcription-PCR (RT-PCR) products were quantified by densitometry of a
photograph of ethidium bromide-stained agarose. The number of PCR cycles was
optimized to measure the amount of mRNA in the linear range, and an analysis
of cycle sequencing revealed that the sequence was identical to position
77-627 in rat CNTF cDNA and 240-664 in rat CNTFR
cDNA. In the
semiquantitative measurement, CNTF and CNTFR
primers were coamplified
with glyceraldehyde-3-phosphate dehydrogenase (GAPDH) primers, and the
CNTF/GAPDH or CNTFR
/GAPDH product ratios were calculated and
considered an index of CNTF or CNTFR
mRNA expressions. Six animals
were used for PCR in each time point, and three measurements were used per
animal. The primers used for CNTF, CNTFR
, and GAPDH amplification are
listed in Table 1.
|
Immunoblotting of CNTF and PCNA
Tissues were homogenized in a buffer containing 10 mmol/L Tris Cl (pH 7.6),
150 mmol/L NaCl, 1% (wt/vol) sodium deoxycholate, 1% (vol/vol) Triton X-100,
0.1% (wt/vol) sodium dodecyl sulfate, 1% (vol/vol) aprotinin, 2 mmol/L Na
3VO 4, and freshly added leupeptin (1 µg/ml),
pepstain (1 µg/ml]), and phenylmethylsulfonyl fluoride (1 mmol/L).
Homogenates were centrifuged at 16,000 x g for 15 min at
4°C, and protein concentrations were determined on supernatants using the
Bradford method protein microassay (Bio-Rad, Hercules, CA). Homogenates were
boiled for 5 min in Laemmli sample buffer. Proteins were separated by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis in 15% polyacrylamide gels
and were electroblotted onto Bio-Blot nitrocellulose (Costar, Cambridge, MA).
Nonspecific binding was blocked by incubating the blots for 1 h in 5% (wt/vol)
nonfat milk. CNTF protein was detected with a monoclonal anti-CNTF antibody
(Chemicon International Inc.), and PCNA protein was detected with anti-PCNA
antibody (PC10, Dako, Copenhagen, Denmark) by incubation overnight. Primary
antibody incubation was followed by six washes with Tris-buffered saline
containing 0.005% Tween 20 (TBS-T). The blots were then incubated with
peroxidase-conjugated antibody, goat anti-mouse IgG for CNTF and mouse
anti-rat IgG for PCNA for 30 min. Antibody-reactive protein was detected using
an enhanced chemiluminescence kit (Amersham Life Science, Buckinghamshire,
UK). Densitometric analysis was performed using Imagemaster VDS software
(Pharmacia Biotech, Piscataway, NJ). Six animals were used for PCR in each
time point, and three measurements were used per animal.
In Situ Hybridization for CNTFR 
The riboprobe for CNTFR
used in the present study was kindly
provided by Dr. H. D. Hofmann
(21). After dewaxing, the
sections were treated in 0.2 N HCl for 20 min and incubated in 20 µg/ml
pepsin (0.1 N HCl) for 20 min at room temperature, which was followed by three
washes with PBS. Prehybridization and hybridization steps were carried out at
53°C for 1 h and 15 h, respectively. The prehybridization buffer was
composed of 50% formamide, 4 x SSC, 10% dextran sulfate, 1 x
Denhardt's solution, and 1 µg/µl salmon sperm DNA. The hybridization
buffer was identical with the prehybridization buffer except that salmon sperm
DNA was substituted by 150 ng/µl CNTFR
riboprobe. After
posthybridization washing, sections were incubated with antidigoxigenin
antiserum conjugated with alkaline phosphatase (Boehringer Mannheim, Mannheim,
Germany), and histochemical detection was then performed using the 4-Nitroblue
tatrazolium chloride/5-Bromo-4-chloro-3-indolyl-phosphate mixture (Boehringer
Mannheim).
Statistical Analyses
Data reported are mean ± SEM, and all statistical analyses were
calculated with SYSTAT for Macintosh v. 5.2 (SYSTAT Inc., Chicago, IL). The
sham-operated rats showed no significant variations at any time point, so the
data at day 1 were used as a control reference. Comparisons between these data
and those for I/R rats were analyzed using analyzed using the t test,
and the level assumed for statistical significance was P <
0.05.
| Results |
|---|
|
|
|---|
|
Expression of CNTF mRNA and Protein in Rat Kidneys with Sham
Operation and I/R Injury
CNTF mRNA expression in the cortex and the medulla began to increase on
days 1 to 2 and was maximal on days 5 to 7. It then gradually decreased
(Figure 2). Expression of CNTF
protein (Figure 3) was similar
to CNTF mRNA expression. In the cortex
(Figure 3A), a very faint band
for CNTF protein was detected in sham-operated rat kidney. With I/R injury,
CNTF protein began to increase on day 1 and achieved a maximum on day 7. The
relative optical densities in each lane, taking day 1 as a 100% reference
point, were as follows: day 1, 100%; day 2, 791%; day 3, 622%; day 5, 791%;
day 7, 1600%; day 14, 278%; and day 28, 239%. The pattern of CNTF expression
in the medulla was similar to that of the cortex
(Figure 3B). The relative
optical densities of CNTF protein were as follows: day 1, 99%; day 2, 305%;
day 3, 250%; day 5, 265%; day 7, 433%; day 14, 272%; and day 28, 295%.
|
|
Localization of CNTF Protein in Rat Kidneys with Sham Operation and
I/R Injury
In rat kidneys with sham operations, CNTF immunoreactivity was observed
only in the descending thin limb of the loop of Henle
(Figure 4, A and B). With I/R
injury, CNTF expression began to appear in the outer part of the outer stripe
of the outer medulla (OSOM) (Figure
4C) and progressively expanded into the cortex and the OSOM up to
7 d (Figure 4, D and E).
Thereafter, CNTF expression in the cortex and OSOM decreased gradually
(Figure 4F). The CNTF-positive
cells in the OSOM were predominantly proximal tubule cells, which were
squamous or cuboidal in shape and had less developed apical microvilli
(Figure 5, A and B). In
contrast, the exfoliated cells showed no CNTF immunoreactivity
(Figure 5A).
|
|
Immunoelectron microscopy showed densely immunostained cells with no or poorly developed apical microvilli (Figure 5C). These cells seemed to be regenerating large and bright nuclei with prominent nucleoli, many mitochondria and free ribosomes, and intact intercellular junctions and basal lamina.
Expression of CNTFR
mRNA in Rat Kidneys after Sham Operation
and I/R Injury
The expression pattern of CNTFR
mRNA was similar to that of the
CNTF protein. The expression of CNTFR
mRNA in the medulla
(Figure 6) was increased on day
1 (0.24 ± 0.05 versus 0.55 ± 0.10; P <
0.05) and on day 2 (versus 0.65 ± 0.11; P < 0.05)
as compared with the sham-operated rat. This increase of CNTFR
mRNA
was observed up to day 7 (versus 0.50 ± 0.11; P <
0.05), but thereafter its levels were progressively decreased (day 14,
versus 0.38 ± 0.05; day, 28; versus 0.24 ±
0.05).
|
Localization of CNTFR
mRNA in Rat Kidneys with Sham Operation
and I/R Injury
In agreement with results from RT-PCR, the hybridization signal of CNTFR
mRNA was detectable in sham-operated rat kidneys
(Figure 7, A through C). With
I/R injury, CNTFR
mRNA expression progressively increased in both the
renal cortex and the medulla up to day 7
(Figure 7, D through F). The S3
segment of the proximal tubules in the OSOM showed the most prominent increase
in signal (Figure 8B). In the
cortex, the initial part of the proximal tubules, continuous with the
glomerular urinary pole, and the S2 segment of the proximal tubules in the
medullary ray showed strong signal intensity (Figures
7F and
8A). Thereafter, in
situ signals of CNTFR
mRNA decreased gradually, but a moderate
level of CNTFR
mRNA was observed in the thick ascending limb of the
inner stripe of the outer medulla (ISOM) on day 28 (Figures
7G and
8C).
|
|
| Discussion |
|---|
|
|
|---|
The presence of CNTF and CNTFR
in rat kidney is still
controversial. Stöckli et al.
(22) reported that CNTF mRNA
is undetectable in the kidney, but Ohta et al.
(12,13)
reported that CNTF mRNA and protein are present. For CNTFR
, Davis
et al. (23) first
reported that it is expressed exclusively within the nervous system and
skeletal muscle. These discrepant results seem to be related to the low level
of CNTF and CNTFR
in the kidney. In the present study, the presence of
both CNTF and CNTFR
was confirmed with RT-PCR and/or immunoblotting,
and their specific locations were established with the use of
immunohistochemistry or in situ hybridization.
The anatomic location of CNTF-producing cells is important if we are to understand the possible role of CNTF in rat kidney with I/R. In general, ischemic renal injury in rat induces growth factors at the distal (S3) segment of the proximal tubule (1,24). This site is the most vulnerable to I/R injury (25). Our study showed a significant increase in CNTF immunoreactivity in the S3 segment of the proximal tubule, a site at which CNTF normally is not expressed. Further study of proximal tubules using electron microscopy revealed that CNTF-positive cells were morphologically similar to regenerating tubular cells. Conversely, there was no immunoreactivity of CNTF in the detached or exfoliated tubular cells. These immunohistochemical and electron microscopic studies provide evidence that the primary source of induced CNTF is regenerating proximal tubular cells and that necrotic cells do not produce CNTF in rat kidney with I/R injury.
The proliferative activity of tubular cells is maximal at 2 to 3 d and on day 7 in rat kidneys after I/R injury (26). This biphasic pattern was confirmed in this study using PCNA immunoblotting (Figure 1). During this period, several growth factors seem to be working in a coordinated manner. The expressions of epidermal growth factor (day 1) and hepatocyte growth factor (6 to 12 h) are maximal during the early phase, and insulin-like growth factor-1 is detectable at 3 to 7 d (5). In the present study, CNTF expression was maximal on day 7 (16-fold in the cortex, 4.3-fold in the medulla as compared with the control group). This finding suggests that CNTF regulates processes that occur later, such as redifferentiation of kidney epithelia.
Distribution of the CNTF receptor is also important as CNTF signal depends
on CNTF binding to CNTFR
, and this process is essential for the
trophic effect of CNTF to occur
(27). Our study shows the
close relationship between CNTF and CNTFR
in location as well as
expression pattern after I/R injury. Both CNTF and CNTFr
were strongly
expressed on the regenerating proximal tubular cells or were expressed on
tubules located close by (CNTF in the descending thin limb of Henle's loop;
CNTFR
in the thick ascending limb). In addition, a similar expression
pattern of CNTF and CNTFR
was observed during the regeneration period.
This suggests that interaction between CNTF and CNTFR
is mediated by
the autocrine or paracrine mechanism during the course of regeneration after
injury.
Our study demonstrates the striking increase of CNTF in the rat kidney
after I/R injury, but the mechanism that regulates CNTF expression is unknown.
In the absence of injury, neurotrophic protein cannot be secreted, because
there is no signal sequence that could allow its secretion according to the
classical vesicular mechanism
(22). Moreover, several
studies failed to demonstrate the release of significant amounts of the
protein by cultured CNTF-expressing cells
(28,29).
This has fostered the belief that CNTF can be released only from damaged
cells. Recently, evidence was presented for release of CNTF through other
secretory pathways that do not require conventional signal sequences. Cultured
astrocytes could be stimulated by exogenous cytokines, for example, by
interleukin-1 and tumor necrosis factor-
, to secrete CNTF
(30). Interestingly, these two
cytokines are implicated in the pathogenesis of I/R injury and upregulated in
renal tubular cells with I/R injury
(31,32).
Therefore, we speculate that inflammatory cytokines produced after I/R injury
may be responsible for the CNTF production in regenerating renal tubular
cells. In vitro study will be needed to define the roles of these
cytokines in regulating CNTF expression in normal and injured conditions.
In summary, our study demonstrates the upregulation of CNTF and CNTFR
at regenerating renal tubular cells after I/R injury. This finding
suggests a role for CNTF as a growth factor in renal tissue repair.
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
component of the CNTF
receptor is required for signaling and defines potential CNTF targets in the
adults and during development. Neuron10
: 89-102,1993[Medline]
This article has been cited by other articles:
![]() |
C. P.K. Lai, J. F. Bechberger, R. J. Thompson, B. A. MacVicar, R. Bruzzone, and C. C. Naus Tumor-Suppressive Effects of Pannexin 1 in C6 Glioma Cells Cancer Res., February 15, 2007; 67(4): 1545 - 1554. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-H. Han, U-Y. Lee, Y.-S. Jang, Y. M. Cho, Y. M. Jang, I.-A Hwang, J. Y. Ghee, S.-W. Lim, W.-Y. Kim, C. W. Yang, et al. Differential regulation of B/K protein expression in proximal and distal tubules of rat kidneys with ischemia-reperfusion injury Am J Physiol Renal Physiol, January 1, 2007; 292(1): F100 - F106. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Ozog, S. M. Bernier, D. C. Bates, B. Chatterjee, C. W. Lo, and C. C.G. Naus The Complex of Ciliary Neurotrophic Factor-Ciliary Neurotrophic Factor Receptor {alpha} Up-Regulates Connexin43 and Intercellular Coupling in Astrocytes via the Janus Tyrosine Kinase/Signal Transducer and Activator of Transcription Pathway Mol. Biol. Cell, November 1, 2004; 15(11): 4761 - 4774. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yoshino, T. Monkawa, M. Tsuji, M. Hayashi, and T. Saruta Leukemia Inhibitory Factor Is Involved in Tubular Regeneration after Experimental Acute Renal Failure J. Am. Soc. Nephrol., December 1, 2003; 14(12): 3090 - 3101. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Ozog, J. F. Bechberger, and C. C. G. Naus Ciliary Neurotrophic Factor (CNTF) in Combination with Its Soluble Receptor (CNTFR{alpha}) Increases Connexin43 Expression and Suppresses Growth of C6 Glioma Cells Cancer Res., June 1, 2002; 62(12): 3544 - 3548. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |